Cargando…
IL-33/ST2 promotes the malignant progression of gastric cancer via the MAPK pathway
Gastric cancer (GC) remains one of the commonest malignant tumors and the second leading cause of cancer-related deaths worldwide. IL-33 is highly expressed in tumor tissues and serum of patients with GC. However, the function of the IL-33 and IL-33 receptor ST2 in the malignant progression of GC is...
Autores principales: | Huang, Ning, Cui, Xing, Li, Wen, Zhang, Chunlai, Liu, Liqing, Li, Jinxing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985998/ https://www.ncbi.nlm.nih.gov/pubmed/33760194 http://dx.doi.org/10.3892/mmr.2021.12000 |
Ejemplares similares
-
The ST2/Interleukin-33 Axis in Hematologic Malignancies: The IL-33 Paradox
por: Allegra, Alessandro, et al.
Publicado: (2019) -
The Role of IL-33/ST2 Pathway in Tumorigenesis
por: Larsen, Kristen M., et al.
Publicado: (2018) -
The IL-33/ST2 Pathway in Cerebral Malaria
por: Glineur, Corine, et al.
Publicado: (2022) -
Upregulation of the IL-33/ST2 pathway in dry eye
por: Wang, Shudan, et al.
Publicado: (2019) -
IL-33-ST2 Axis in Liver Disease: Progression and Challenge
por: Sun, Zijian, et al.
Publicado: (2017)